Barclays’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
AC
DCM
Barclays's INGN Position: Q2 2026 in Review
Barclays reduced its Inogen (INGN) stake by 1.1% in Q2 2026, selling an estimated $3.18K and leaving 42,607 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #3536.
Barclays first reported a position in INGN in Q1 2014 and has held it in 50 quarters since. The position peaked at $3.79M in Q4 2015. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.
- Barclays held 42,607 shares of Inogen worth $275K as of Q2 2026.
- Barclays sold 480 Inogen shares in Q2 2026, an estimated $3.18K.
- Inogen made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3536 holding.
- Barclays first reported a position in Inogen in Q1 2014 and has held it in 50 quarters since.
- Barclays's Inogen position peaked at $3.79M in Q4 2015.
- 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.